REGNON

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.

NaamREGNON

PositieNo.3701

Marktkapitalisatie$0.00

Volledig verwaterde marktkapitalisatie$0.00

Marktaandeel%

Handelsvolume/marktkapitalisatie (24 uur)152,012,708.57%

Circulerende voorraad0.47853416

Maximale voorraad0

Totale voorraad0.47853416

Circulatiesnelheid%

Uitgiftedatum--

De prijs waartegen het actief voor het eerst werd uitgegeven--

Hoogste prijs ooit778.9210127183559,2026-04-02

Laagste prijs671.4998645317189,2026-04-30

Publieke blockchainETH

InleidingRegeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.

Sector

Sociale media

• Officiële website
• Blokverkenner

etfindex:mc_etfindex_sourceDisclaimer: De door cmc verstrekte gegevens mogen niet worden beschouwd als beleggingsadvies.